How to use Tisotumab vedotin-tftv

The recommended dose of Vedotin-Tisotumab vedotin-tftv is 2 mg/kg, with a maximum dose of 200 mg for patients ≥100 kg, as a 30-minute intravenous infusion every 3 weeks until disease progression or unacceptable toxicity. If the patient experiences adverse reactions and other uncomfortable symptoms after use, the drug dosage should be adjusted under the guidance of a doctor. The first dose of Vitin-Tisotuzumab was reduced to 1.3 mg/kg and the second dose was reduced to 0.9 mg/kg; patients who could not tolerate 0.9 mg/kg were permanently discontinued.

Vitin-Tisotuzumab injection is a powder mixed with liquid that is injected intravenously (into a vein) over 30 minutes by a doctor or nurse at a hospital or medical facility, usually on the first day of a 21-day cycle. Your doctor will prescribe 3 different eye drops for use during treatment with Vitin-Tesotuzumab Injection to reduce the risk of eye problems. Eye drops should be brought to each treatment appointment. Your doctor or nurse will place a cold pack on the eye while the patient receives Vertin-Tesotuzumab Injection. Doctors may delay or stop treatment with Vitin-Tisotuzumab Injection or use another drug pair, depending on the patient's response to the drug and any side effects experienced.

Vitin-TisotumabThe original drug has not yet been marketed in China, so it cannot be included in medical insurance. The original drugs marketed overseas are very expensive. The price of each box of 40 mg/vial may be around RMB 90,000 (the price may fluctuate due to the exchange rate). Currently, there is no generic version of Vitin-Tisotuzumab on the market. For more drug information and specific prices, please consult the medical consultant of the drug.